Rocket Doctor AI Inc. (AIDR.CN) Stock Price, News, Quote & History

Aug 7, 2026
rocket-doctor-ai-inc-(aidr.cn)-stock-price,-news,-quote-&-history

We are experiencing some temporary issues. The market data on this page is currently delayed.

Canadian Sec – Free Realtime Quote CAD

0.6000 +0.0100 (+1.69%)

As of August 5 at 3:55:17 p.m. EDT. Market Open.

Chart Range Bar

Loading chart for AIDR.CN

  • Previous Close 0.5900
  • Open 0.0000
  • Bid 0.5800 x —
  • Ask 0.5900 x —
  • Day’s Range 0.0000 – 0.0000
  • 52 Week Range 0.0000 – 0.9800
  • Volume 12,019
  • Avg. Volume 168,060
  • Market Cap (intraday) 58.137M
  • Beta (5Y Monthly) -0.33
  • PE Ratio (TTM)
  • EPS (TTM) -0.2300
  • Earnings Date
  • Forward Dividend & Yield
  • Ex-Dividend Date
  • 1y Target Est 1.55

Rocket Doctor AI Inc. provides personalized health care information services in Canada and United States. The company develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management. It also offers a digital health app, an assessment tool which provides insights about health. In addition, the company provides medical education, medical clinic, and clinical advisor solutions; and offers healthcare information resource. Rocket Doctor AI Inc. was formerly known as Treatment.com AI Inc. and changed its name to Rocket Doctor AI Inc. in August 2025. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.

www.treatment.com

December 31

Fiscal Year Ends

Health Information Services

Industry

Trailing total returns as of 2026-08-06, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

S&P/TSX Composite index (^GSPTSE)

13.67%

1-Year Return

S&P/TSX Composite index (^GSPTSE)

29.74%

3-Year Return

S&P/TSX Composite index (^GSPTSE)

79.00%

5-Year Return

S&P/TSX Composite index (^GSPTSE)

76.91%

View More

Analyst Price Targets

 

Analyst Recommendations

  • Strong Buy

  • Buy

  • Hold

  • Underperform

  • Sell

 

View More

Valuation Measures

As of 2026-07-31

  • Market Cap

    55.23M

  • Enterprise Value

    52.26M

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

    18.64

  • Price/Book (mrq)

    8.89

  • Enterprise Value/Revenue

    21.10

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -221.31%

  • Return on Equity (ttm)

  • Revenue (ttm)

    38.14k

  • Net Income Avi to Common (ttm)

    -2.01M

  • Diluted EPS (ttm)

    -0.2300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.3M

  • Total Debt/Equity (mrq)

    46.41%

  • Levered Free Cash Flow (ttm)

    -1.01M

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Leave a comment